Sheller in “Will A Court Ruling Usher In Off-Label Promotions?”



A U.S. Appeals Court ruling that pitted free speech rights versus off-label promotion of pharmaceuticals has raised speculation that 2013 may usher in the sort of aggressive marketing by drug makers that has previously drawn the wrath of federal prosecutors.


Previous post

Sheller Risperdal settlements front page Legal Intelligencer

Next post

Sheller Gift Establishes Social Justice Center at Temple University Beasley School of Law